Correlation Between Cns Pharmaceuticals and Annexon
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Annexon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Annexon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Annexon, you can compare the effects of market volatilities on Cns Pharmaceuticals and Annexon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Annexon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Annexon.
Diversification Opportunities for Cns Pharmaceuticals and Annexon
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cns and Annexon is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Annexon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexon and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Annexon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexon has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Annexon go up and down completely randomly.
Pair Corralation between Cns Pharmaceuticals and Annexon
Given the investment horizon of 90 days Cns Pharmaceuticals is expected to under-perform the Annexon. In addition to that, Cns Pharmaceuticals is 1.42 times more volatile than Annexon. It trades about -0.12 of its total potential returns per unit of risk. Annexon is currently generating about 0.04 per unit of volatility. If you would invest 525.00 in Annexon on August 29, 2024 and sell it today you would earn a total of 4.00 from holding Annexon or generate 0.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cns Pharmaceuticals vs. Annexon
Performance |
| Timeline |
| Cns Pharmaceuticals |
| Annexon |
Cns Pharmaceuticals and Annexon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cns Pharmaceuticals and Annexon
The main advantage of trading using opposite Cns Pharmaceuticals and Annexon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Annexon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexon will offset losses from the drop in Annexon's long position.| Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
| Annexon vs. Eliem Therapeutics | Annexon vs. Scpharmaceuticals | Annexon vs. Milestone Pharmaceuticals | Annexon vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |